Longitudinal (2001–14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010–13) analysis of oritavancin in vitro potency-Reference-Cited by-同舟云学术

Longitudinal (2001–14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010–13) analysis of oritavancin in vitro potency

Published:2016-09-08 Issue:12 Volume:71 Page:3453-3458
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Mendes Rodrigo E.,Castanheira Mariana,Farrell David J.,Flamm Robert K.,Sader Helio S.,Jones Ronald N.

Funder

The Medicines Company

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/71/12/3453/13760975/dkw319.pdf

Reference17 articles.

1. Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010

2. ECDC. Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals 2011–2012 . 2013. http://ecdc.europa.eu/en/publications/Publications/healthcare-associated-infections-antimicrobial-use-PPS.pdf .

3. Murray PR , Baron EJ , Jorgensen JH et al . Manual of Clinical Microbiology , 9th edn. Washington, DC: ASM Press, 2007.

4. Antibiotic resistance inEnterococcus faeciumclinical isolates

5. The Medicines Company. Orbactiv™. http://www.orbactiv.com/ .

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ampicillin-susceptible Enterococcus faecium infections: clinical features, causal clades, and contribution of MALDI-TOF to early detection;Microbiology Spectrum;2023-10-17

2. Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010–2019);Journal of Chemotherapy;2023-09-25

3. Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review;Expert Review of Anti-infective Therapy;2023-06-14

4. The Hidden Cost of COVID-19: Focus on Antimicrobial Resistance in Bloodstream Infections;Microorganisms;2023-05-16

5. Risk Factors and the Impact of Multidrug-Resistant Bacteria on Community-Acquired Urinary Sepsis;Microorganisms;2023-05-13